Investing.com - Chemed (NYSE:CHE) reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Chemed announced earnings per share of $3.78 on revenue of $526.5M. Analysts polled by Investing.com anticipated EPS of $4.65 on revenue of $527.05M.
Chemed shares are down 24.3% from the beginning of the year, still down 11.58% from its 52 week high of $539.87 set on December 30, 2021.
Chemed follows other major Healthcare sector earnings this month
Chemed's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar